School
School of Pharmacy
Department
Pharmacy Practice
Office Location
White 350
Boston
Office Phone Office Phone: 617.732.2938
About
Dr. Alissa Segal is a clinical pharmacist and Certified Diabetes Care and Education Specialist. She completed postgraduate pharmacy residencies at the Medical Center at Princeton and the Medical University of South Carolina.
In 2007, Dr. Segal joined MCPHS and established clinical pharmacy services at the Joslin Diabetes Center, where she contributed to patient care, scholarship, and education. In 2023, she joined the Diabetes Program at Brigham and Women’s Hospital.
Her work in diabetes care has led to numerous publications and contributions to the American Diabetes Association’s Standards of Care for Diabetes, as well as the development of patient and professional education initiatives with national and international diabetes organizations.
Education
- PharmD – Drake University
- PGY-2 Residency, Primary Care – Medical University of South Carolina
- PGY-1 Residency, Pharmacy Practice – Medical Center at Princeton
- Scholar’s Program, General Clinical Research Center – University of New Mexico Health Sciences Center
- Certified Diabetes Technology Clinician
- Certified Diabetes Care & Education Specialist
Research Interests
- Diabetes
- Cardiometabolic disease
- Professional Education
Featured Affiliations
American Diabetes Association
WebsiteAmerican College of Clinical Pharmacy
WebsiteDiabetes Education For All
WebsiteEducation
- PharmD – Drake University
- PGY-2 Residency, Primary Care – Medical University of South Carolina
- PGY-1 Residency, Pharmacy Practice – Medical Center at Princeton
- Scholar’s Program, General Clinical Research Center – University of New Mexico Health Sciences Center
- Certified Diabetes Technology Clinician
- Certified Diabetes Care & Education Specialist
Research Interests
- Diabetes
- Cardiometabolic disease
- Professional Education
Peer-Reviewed Articles & Book Chapters
Selected Peer-Reviewed Journal Articles- El Sayed, N., AlHarbi, M., Alaama, T., Osani, M., Matfin, G., Segal, A.R., Gabbay, R.A., Bannuru, R.R. (2025) A Holistic Evaluation of clinical Competence and Professional Attitudes in Diabetes Health Care: Insights From a Multinational Cohort. Clin Diabetes; cd240046. https://doi.org/10.2337/cd24-0046.
- Alolayan, S., Eguale, T., Segal, A.R., Doucette, J., Rittenhouse, B.E. (2025) Incremental Cost-Effectiveness Ratios (ICERs) and Revised Metformin Cost-Effectiveness Conclusions in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study. Am J Lifestyle Med, e-publication before print https://doi.org/10.1177/15598276251315415
- American Diabetes Association Professional Practice Committee. (2025) 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025. Diabetes Care; 48 (Suppl 1): S181–S206. https://doi.org/10.2337/dc25-S009
- American Diabetes Association Professional Practice Committee. (2025) 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024. Diabetes Care; 48 (Suppl 1): S207–S238. https://doi.org/10.2337/dc25-S010
- American Diabetes Association Professional Practice Committee. (2025) 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025. Diabetes Care; 48 (Suppl 1): S239–S251. https://doi.org/10.2337/dc25-S011
- Neumiller, J.J., Bajaj, M., Bannuru, R.R., McCoy, R.G., Pekas, E.J., Segal, A.R., El Sayed, N.A. (2024) Compounded GLP 1 and Dual GIP/GLP 1 Receptor Agonists: A Statement from the American Diabetes Association. Diabetes Care; 47: https://doi.org/10.2337/dci24-0091
- Rittenhouse, B.E., Alolayan, S., Eguale, T., Segal, A.R., Doucette, J. (2024) Metformin in the Diabetes Prevention Program 3 Year Trial: The Cost Effectiveness that Never Was. Diabetes Obes Metab, 26:5097-106.
- American Diabetes Association Professional Practice Committee. (2024) 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024. Diabetes Care; 47 (Suppl 1): S158–S178. https://doi.org/10.2337/dc24-S009
- American Diabetes Association Professional Practice Committee. (2024) 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024. Diabetes Care; 47 (Suppl 1): S179–S218. https://doi.org/10.2337/dc24-S010
- American Diabetes Association Professional Practice Committee. (2024) 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2024. Diabetes Care; 47 (Suppl 1): S219–S230. https://doi.org/10.2337/dc24-S011
- Weinrach, L.A., Claggett, B.L., Liu, J., Segal, A.R., Woodward, J., D’Elia, J.A. (2020) SGLT-2 inhibitors may be targeting higher risk patients with diabetes possibly justifying higher cost: Single center repeated cross-sectional analysis. J Diabetes and its Complications. https://doi.org/10.1016/j.jdiacomp.2020.107761
- Pai, A.B., Divine, H., Marciniak, M., Morreale, A., Saseen, J.J., Say, K., Segal, A.R., Norton, J.M., Narva, A.S. (2018) Need for a judicious approach to using non-steroidal anti-inflammatory drugs: focus on avoiding community-acquired acute kidney injury. Annals of Pharmacotherapy, 53(1):95-100. doi:10.1177/1060028018789174
- Ganda, O.P., Segal, A., Blair, E., Beaser, R., Gaglia, J., Halprin, E., Gabbay, R.A. (2018) Chapter 5. Clinical guideline for pharmacological management of adults with type 2 diabetes. American Journal of Managed Care, 24 (7 Spec No.):SP253-SP262.
- Ovalle, F., Segal, A.R., Anderson, J.E., Cohen, M.R., Morwick, T.M., Jackson, J.A. (2017) Understanding concentrated insulins: a systematic review. Current Medical Research and Opinion, 34(6):1029-43. doi: 10.1080/03007995.2017.1409426
- Weinrauch, L.A., Segal, A.R., Bayliss, G.P., Liu, J., Wisniewski, E., D’Elia, J.A. (2017) Changes in treatment of hyperglycemia in a hypertensive type 2 population as renal function declines. Clinical Kidney Journal. 10(5):661-5.
- D’Elia, J,A., Segal, A.R., Bayliss, G., Weinrauch, L.A. (2017) Sodium glucose co-transport-2 inhibition and acidosis in Type 2 diabetic patients: a review of FDA data and possible conclusions. International Journal of Nephrology and Renovascular Disease, 10:153-8.
- Munshi, M.N., Slyne, C., Segal, A., Saul, N., Lyons, C., Weinger, K. (2017) Liberating A1C goals in older adults may not protect against the risk of hypoglycemia. J Diabetes and its complications, 31(7):1197-1199.
- Weinrauch, L.A., Segal, A.R., D’Elia, J.A. (2017) Metformin-SGLT2, dehydration and acidosis potential. J Am Geriatr Soc, 65(5):e101-2.
- Segal, A.R., Vootla, T., Beaser, R.S. (2016) Insulin – Making Sense of Current Options. Endocrinol Metab Clin North Am, 45(1):845-874.
- Weinrauch, L.A., Segal, A.R., D’Elia, J.A. (2016) Cardiovascular risk reduction and the community pharmacist. In Press - J Am Coll Cardiology, 67(24):2855-2857.
- Munshi, M.N., Segal, A.R., Saul, N., Slyne, C., Lyons, C.M., Weinger, K. (2016) Simplification of insulin regimen in older adults improve risk of hypoglycemia without compromising glycemic control. JAMA Intern Med, 176(7):1023 doi:10.1001/jamainternmed.2016.2288
- Weinrauch L.A., Bayliss, G., Segal, A.R., Liu, J., Wisniewski, E., D’Elia, J.A. (2016) Treating hypertension in diabetic patients with advanced chronic kidney disease: what should we have in mind? J Clin Hypertens, 18(10):1077-8. doi:10.1111/jch.12839 [early view, on-line]
- Weinrauch L.A., Bayliss, G., Segal, A.R., Liu, J., Wisniewski, E., D’Elia, J.A. (2016) Renal function alters antihypertensive regimens in type 2 diabetes patients. J Clin Hypertension, 18(9):878-83. doi:10.11/jch.12776
- Munshi, M.N., Segal, A.R., Slyne, C., Samur, A.A., Brooks, K.M., Horton, E.S. (2015) Shortfalls of the use of HbA1c-derived eAG in older adults with diabetes. Diabetes Res Clin Pract. 110(1):60-5.
- Costa, M.D., Henriques, T., Munshi, M.N., Segal, A.R., Goldberger, A.L. (2014) Dynamical Glucometry: Use of multiscale entropy analysis in diabetes. Chaos: An Interdisciplinary Journal of Nonlinear Science. 24, 033139-1-5.
- Henriques, T., Munshi, M.N., Segal, A.R., Costa, M.D., Goldberger, A.L. (2014) Glucose-at-a-glance: new method to visualize the dynamics of CGM data. J Diabetes Sci and Technol. 8(2):299-306
- Munshi, M.N., Segal, A.R., Suhl, E., Ryan, C., Sternthal, A., Giusti, J., Lee, Y., Fitzgerald, S., Staum, E., Bonsignor, P., DesRochers, L., McCartney, R., Weigner, K. (2013) Assessment of Barriers to Improve Diabetes Management in Older Adults: A randomized controlled study. Diabetes Care, 36(3):543-9.
- Munshi ,M., Maguchi, M., Segal, A. (2012) Treatment of type 2 diabetes in the elderly. Current Diabetes Reports. 12(3):239-245
- Munshi, M.N., Segal, A.R., Suhl, E., Staum, E., Desrocher,s L., Sternthal, A., Giusti, J., McCartney, R., Lee, Y., Bonsignore, P,, Weinger, K. (2011) Frequent hypoglycemia among older adults with poor glycemic control. Archives of Internal Medicine. 171(4):362-364.
- Segal, A.R., Brunner, J.E., Burch, F.T., Jackson, J.A. (2010) Highly-concentrated (U-500 Human Regular) insulin use in patients with diabetes: a primer for outpatient and inpatient pharmacists. American Journal of Health System Pharmacists, 67;1526-1535.
- Shelley, B.M., Sussman, A.L., Williams, R.L., Segal, A.R., Crabtree, B.F. (2009) “They don’t ask me so I don’t tell them”: Patient-Clinician Communication about Traditional, Complementary and Alternative Medicine. Annals of Family Medicine, 7(2):139-147.
- Boyce, E.G., Burkiewicz, J.S., Haase, M.R., MacLaughlin, E.J., Segal, A.R., Chung, E.P., Chan, L.N., Rospond, R.M., Barone, J.A., Durst, S.W., Wells, B.G. (2009) ACCP Position Statement: Clinical Pharmacy Development. Pharmacotherapy, 29(1):124-126.
- Munsh,i M.N., Segal, A.R. (2008) Insulin therapy for older adults with diabetes. Geriatrics & Aging, 11(6):357-362.
- Campbell, H.M., Raisch, D.W., Sather, M.R., Segal, A.R., Warren, S.R.(2008) Impact of a Clinical Trials Information Handbook on Patient Knowledge, Perceptions and Likelihood of Participation. IRB: Ethics & Human Research, 30(1):6-14.
- Boyce, E.G., Burkiewicz, J.S., Haase, M.R., MacLaughlin, E.J., Segal, A.R., Chung, E.P., Chan, L.N., Rospond, R.M., Barone, J.A., Durst, S.W., Wells, B.G. (2007) ACCP White Paper: Essential Components of a Faculty Development Program for Pharmacy Practice Faculty. Pharmacotherapy. E-pub accessible October, 2007 at http://www.accp.com/position/FacDevWPFinal_nd.pdf
- Segal, A.R., Doherty, K.M., Leggott, J., Zlotoff, B. (2007) Cutaneous Reactions to Drugs in Children. Pediatrics, 120 (4), e1-e17.
- Campbell, H.M., Raisch, D.W., Sather, M.R., Segal, A.R., Warren, S.R. (2007) A Comparison of Veteran and Nonveteran Motivations and Reasons for Participating in Clinical Trials. Military Medicine, 172(1), 27-30.
- El Sayed N., Ritter, M.J., Segal, A.R. Management of Concentrated Insulins in Acute Care Settings. In: Matfin, G., editor. Endocrine and Metabolic Medical Emergencies, 2nd Ed. Oxford, UK: John Wiley & Sons, Ltd; 2018, p 560-570.
- Hamdy, O., Abrahamson, M.A., Segal, A.R. Management of U-500 Insulin in Hospitalized Patients. In: Matfin, G., editor. Endocrine and Metabolic Medical Emergencies. Washington, DC: Endocrine Society; 2014, p. 295-300.
- Beaser, R., Segal, A.R. Chapter 8: Pharmacotherapy of Type 2 Diabetes: Medications to Match the Pathophysiology. In: Joslin Deskbook 3rd Ed. Boston: Joslin Diabetes Center; 2014, p. 211-314.
- Shelley, B., Sussman, A.L., Williams, R., Segal, A.R., Crabtree, B. Chapter 15: ‘They don’t ask me so I don’t tell them’: Patient—clinician communication about traditional, complementary and alternative medicine. In: Adams, J. Traditional, Complementary and Integrative Medicine. Houndmills, Basingstroke, Hampshire: Palgrave Macmillan; 2012, p. 135-141.
- Burge, M.R., Gamache, L., Pai, H., Segal, A.R.. Chapter 25: Hypoglycemia and Home Monitoring. In: Munshi, M.N. Geriatric Diabetes. New York: Informa Healthcare. pp.331-356.
More Affiliations
- International Alliance for Diabetes Action
- Certification Board of Diabetes Care and Education
- International Pharmaceutical Federation
- American Association of Colleges of Pharmacy